About Varex Imaging Corporation
https://www.vareximaging.comVarex Imaging Corporation designs and manufactures X-ray imaging components. The company operates in two segments, Medical and Industrial.
CEO
Sunny S. Sanyal
Compensation Summary
(Year 2025)
Salary $815,816
Stock Awards $2,662,978
Incentive Plan Pay $1,131,894
All Other Compensation $24,000
Total Compensation $4,634,688
Industry Medical - Devices
Sector Healthcare
Went public January 23, 2017
Method of going public Reverse Merger
Full time employees 2,300
ETFs Holding This Stock
Summary
Total 101
Showing Top 3 of 101
Ratings Snapshot
Rating : B-
Discounted Cash Flow 4
Return On Equity 1
Return On Assets 1
Debt To Equity 3
Price To Earnings 1
Price To Book 4
Overall Score 2
Most Recent Analyst Grades
Grade Summary
Buy 1
Outperform 1
Showing Top 2 of 2
Price Target
Target High $17
Target Low $17
Target Median $17
Target Consensus $17
Institutional Ownership
BLACKROCK INC.
Shares:7.15M
Value:$97.74M
PZENA INVESTMENT MANAGEMENT LLC
Shares:4.23M
Value:$57.83M
BLACKROCK, INC.
Shares:4.02M
Value:$54.99M
Summary
% Of Shares Owned 90.02%
Total Number Of Holders 226
Showing Top 3 of 226
Market Cap $548.14 M
52w High $15.46
52w Low $6.76
P/E -8.05
Volume 298.88K
Outstanding Shares 41.40M
About Varex Imaging Corporation
https://www.vareximaging.comVarex Imaging Corporation designs and manufactures X-ray imaging components. The company operates in two segments, Medical and Industrial.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $228.9M ▲ | $58.2M ▼ | $12.2M ▲ | 5.33% ▲ | $0.29 ▲ | $22M ▲ |
| Q3-2025 | $203M ▼ | $148.2M ▲ | $-89.1M ▼ | -43.89% ▼ | $-2.15 ▼ | $-71.1M ▼ |
| Q2-2025 | $212.9M ▲ | $54.6M ▼ | $6.9M ▲ | 3.24% ▲ | $0.17 ▲ | $27.8M ▲ |
| Q1-2025 | $199.8M ▼ | $57.3M ▲ | $-300K ▲ | -0.15% ▲ | $-0.01 ▲ | $17.8M ▲ |
| Q4-2024 | $205.7M | $56.2M | $-50M | -24.31% | $-1.23 | $16.9M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $155.1M ▲ | $1.11B ▲ | $620.8M ▲ | $472.6M ▲ |
| Q3-2025 | $152.6M ▼ | $1.07B ▼ | $603.9M ▼ | $455.3M ▼ |
| Q2-2025 | $223M ▲ | $1.36B ▲ | $793.7M ▲ | $549.7M ▲ |
| Q1-2025 | $212.6M ▲ | $1.33B ▲ | $778M ▲ | $540.2M ▲ |
| Q4-2024 | $200.5M | $1.22B | $667.8M | $535.1M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-89.1M ▼ | $7.7M ▼ | $-700K ▼ | $-201.2M ▼ | $-193.7M ▼ | $1.4M ▼ |
| Q2-2025 | $7.1M ▲ | $16.6M ▲ | $14.7M ▲ | $-700K ▼ | $30.4M ▼ | $9.8M ▲ |
| Q1-2025 | $-100K ▲ | $9.5M ▼ | $-3M ▲ | $124.9M ▲ | $131.4M ▲ | $5.3M ▼ |
| Q4-2024 | $-50M ▼ | $25.9M ▲ | $-14M ▼ | $800K ▲ | $12.6M ▼ | $19.9M ▲ |
| Q3-2024 | $1.4M | $8M | $7.7M | $-1.1M | $14.6M | $3.3M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
 Industrial Segment | $60.00M ▲ | $60.00M ▲ | $60.00M ▲ | $60.00M ▲ |
 Medical Segment | $140.00M ▲ | $140.00M ▲ | $150.00M ▲ | $140.00M ▼ |
Revenue by Geography
| Region | Q4-2024 | Q2-2025 | Q1-2025 | Q3-2025 |
|---|---|---|---|---|
 Americas | $70.00M ▲ | $70.00M ▲ | $60.00M ▼ | $70.00M ▲ |
 Asia Pacific | $70.00M ▲ | $70.00M ▲ | $70.00M ▲ | $60.00M ▼ |
 CHINA | $0 ▲ | $30.00M ▲ | $0 ▼ | $30.00M ▲ |
 EMEA | $70.00M ▲ | $70.00M ▲ | $60.00M ▼ | $70.00M ▲ |
 JAPAN | $0 ▲ | $40.00M ▲ | $0 ▼ | $30.00M ▲ |
 Other Countries | $0 ▲ | $80.00M ▲ | $0 ▼ | $80.00M ▲ |
 UNITED STATES | $70.00M ▲ | $60.00M ▼ | $60.00M ▲ | $60.00M ▲ |
CEO
Sunny S. Sanyal
Compensation Summary
(Year 2025)
Salary $815,816
Stock Awards $2,662,978
Incentive Plan Pay $1,131,894
All Other Compensation $24,000
Total Compensation $4,634,688
Industry Medical - Devices
Sector Healthcare
Went public January 23, 2017
Method of going public Reverse Merger
Full time employees 2,300
ETFs Holding This Stock
Summary
Total 101
Showing Top 3 of 101
Ratings Snapshot
Rating : B-
Discounted Cash Flow 4
Return On Equity 1
Return On Assets 1
Debt To Equity 3
Price To Earnings 1
Price To Book 4
Overall Score 2
Most Recent Analyst Grades
Grade Summary
Buy 1
Outperform 1
Showing Top 2 of 2
Price Target
Target High $17
Target Low $17
Target Median $17
Target Consensus $17
Institutional Ownership
BLACKROCK INC.
Shares:7.15M
Value:$97.74M
PZENA INVESTMENT MANAGEMENT LLC
Shares:4.23M
Value:$57.83M
BLACKROCK, INC.
Shares:4.02M
Value:$54.99M
Summary
% Of Shares Owned 90.02%
Total Number Of Holders 226
Showing Top 3 of 226